nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Annual acknowledgement of manuscript reviewers
|
Chen, Shengdi |
|
2013 |
2 |
1 |
|
artikel |
2 |
Asiaticoside, a trisaccaride triterpene induces biochemical and molecular variations in brain of mice with parkinsonism
|
Sampath, Uvarajan |
|
2013 |
2 |
1 |
|
artikel |
3 |
A two-phase study evaluating the relationship between Thimerosal-containing vaccine administration and the risk for an autism spectrum disorder diagnosis in the United States
|
Geier, David A |
|
2013 |
2 |
1 |
|
artikel |
4 |
Biological function of Presenilin and its role in AD pathogenesis
|
Zhang, Shuting |
|
2013 |
2 |
1 |
|
artikel |
5 |
Can we clinically diagnose dementia with Lewy bodies yet?
|
Huang, Yue |
|
2013 |
2 |
1 |
|
artikel |
6 |
Cell based therapy in Parkinsonism
|
de Munter, Johannes PJM |
|
2013 |
2 |
1 |
|
artikel |
7 |
Changes in Timing and kinematics of goal directed eye-hand movements in early-stage Parkinson’s disease
|
Muilwijk, Danya |
|
2013 |
2 |
1 |
|
artikel |
8 |
Clinic, neuropathology and molecular genetics of frontotemporal dementia: a mini-review
|
Pan, Xiao-dong |
|
2013 |
2 |
1 |
|
artikel |
9 |
Cytometric profiling in various clinical forms of multiple sclerosis with respect to CD21+, CD32+, and CD35+ B and T cells
|
Zandieh, Ali |
|
2013 |
2 |
1 |
|
artikel |
10 |
Deep brain stimulation in Parkinson’s disease
|
Mehanna, Raja |
|
2013 |
2 |
1 |
|
artikel |
11 |
Effects of 17-allylamino-17-demethoxygeldanamycin (17-AAG) in transgenic mouse models of frontotemporal lobar degeneration and Alzheimer’s disease
|
Ho, Shuk Wai |
|
2013 |
2 |
1 |
|
artikel |
12 |
Evidence of neurodegeneration in autism spectrum disorder
|
Kern, Janet K |
|
2013 |
2 |
1 |
|
artikel |
13 |
Insights on altered mitochondrial function and dynamics in the pathogenesis of neurodegeneration
|
McInnes, Joseph |
|
2013 |
2 |
1 |
|
artikel |
14 |
Intranuclear inclusions in a fragile X mosaic male
|
Pretto, Dalyir I |
|
2013 |
2 |
1 |
|
artikel |
15 |
Monoamine oxidase-B (MAO-B) inhibitors: implications for disease-modification in Parkinson’s disease
|
Teo, Kay Cheong |
|
2013 |
2 |
1 |
|
artikel |
16 |
Neurodegenerative changes initiated by presynaptic dysfunction
|
Yasuda, Toru |
|
2013 |
2 |
1 |
|
artikel |
17 |
Progress of basic research in Parkinson’s disease in China: data mini-review from the National Natural Science Foundation
|
Cao, Heqi |
|
2013 |
2 |
1 |
|
artikel |
18 |
Quantitative evaluation of severity of behavioral and psychological symptoms of dementia in patients with vascular dementia
|
Pan, Wei-Dong |
|
2013 |
2 |
1 |
|
artikel |
19 |
Short communication: genetic variations of SLC2A9 in relation to Parkinson’s disease
|
Gao, Jianjun |
|
2013 |
2 |
1 |
|
artikel |
20 |
Social brain dysfunctions in patients with Parkinson’s disease: a review of theory of mind studies
|
Yu, Rwei-Ling |
|
2013 |
2 |
1 |
|
artikel |
21 |
Subthalamic nucleus deep brain stimulation for Parkinson’s disease: 8 years of follow-up
|
Li, Dianyou |
|
2013 |
2 |
1 |
|
artikel |
22 |
Traditional Chinese medicine: a promising candidate for the treatment of Alzheimer’s disease
|
Sun, Zhi-Kun |
|
2013 |
2 |
1 |
|
artikel |
23 |
Translational research in Huntington’s disease: opening up for disease modifying treatment
|
Burgunder, Jean-Marc |
|
2013 |
2 |
1 |
|
artikel |
24 |
Uptake and mitochondrial dysfunction of alpha-synuclein in human astrocytes, cortical neurons and fibroblasts
|
Braidy, Nady |
|
2013 |
2 |
1 |
|
artikel |
25 |
What does complement do in Alzheimer’s disease? Old molecules with new insights
|
Shen, Yong |
|
2013 |
2 |
1 |
|
artikel |